Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.

UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI).

Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.

Medical software company Tomoverse Imaging has closed its seed funding round, securing C$5m ($3.65m) for the development of tvCT.

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

The US FDA has cleared Intuitive's Vessel Sealer Curved for use with the company’s multiport da Vinci surgical systems.

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system.